KindlyMD, Inc. (NASDAQ:NAKA) Given Consensus Rating of “Hold” by Analysts

Shares of KindlyMD, Inc. (NASDAQ:NAKA) have been given an average recommendation of “Hold” by the five analysts that are presently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $30.00.

Several brokerages have recently weighed in on NAKA. Wall Street Zen upgraded shares of KindlyMD to a “sell” rating in a research note on Saturday, May 23rd. Maxim Group decreased their target price on shares of KindlyMD from $60.00 to $30.00 and set a “buy” rating for the company in a research note on Monday, April 6th. Weiss Ratings upgraded shares of KindlyMD from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Monday, May 11th. Finally, TD Cowen assumed coverage on KindlyMD in a research note on Friday, April 10th. They set a “buy” rating and a $40.00 target price for the company.

Insider Transactions at KindlyMD

In other news, CEO David F. Bailey acquired 104,833 shares of KindlyMD stock in a transaction that occurred on Wednesday, May 27th. The shares were purchased at an average cost of $4.84 per share, for a total transaction of $507,391.72. Following the completion of the purchase, the chief executive officer directly owned 3,120,361 shares of the company’s stock, valued at $15,102,547.24. This trade represents a 3.48% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders acquired 191,448 shares of company stock worth $992,908 in the last quarter. Company insiders own 24.49% of the company’s stock.

Hedge Funds Weigh In On KindlyMD

Large investors have recently added to or reduced their stakes in the company. Van ECK Associates Corp bought a new position in KindlyMD during the third quarter worth $111,339,000. Vanguard Group Inc. increased its holdings in shares of KindlyMD by 32,737.0% during the third quarter. Vanguard Group Inc. now owns 6,036,750 shares of the company’s stock valued at $150,557,000 after purchasing an additional 6,018,366 shares during the period. Yorkville Advisors Global LP acquired a new position in shares of KindlyMD during the third quarter valued at $231,942,000. RK Capital Management LLC FL acquired a new position in shares of KindlyMD during the third quarter valued at $239,052,000. Finally, Stratos Wealth Partners LTD. acquired a new position in shares of KindlyMD during the fourth quarter valued at $1,571,000.

KindlyMD Stock Performance

Shares of NASDAQ:NAKA opened at $3.91 on Wednesday. KindlyMD has a 1 year low of $3.89 and a 1 year high of $659.20. The stock has a market capitalization of $68.03 million, a P/E ratio of -0.09 and a beta of 15.84. The stock has a 50-day simple moving average of $6.58 and a 200-day simple moving average of $10.86.

KindlyMD (NASDAQ:NAKA) last issued its earnings results on Wednesday, May 13th. The company reported ($0.38) earnings per share (EPS) for the quarter. KindlyMD had a negative return on equity of 81.32% and a negative net margin of 7,397.12%.The firm had revenue of $2.68 million for the quarter. Analysts predict that KindlyMD will post -16.8 earnings per share for the current year.

About KindlyMD

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.